Cite
HARVARD Citation
Martinello, M. et al. (2018). Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection. Journal of viral hepatitis. 25 (10), pp. 1180-1188. [Online].